Successful plasma therapy for atypical hemolytic uremic syndrome caused by factor H deficiency owing to a novel mutation in the complement cofactor protein domain 15
- 1 February 2005
- journal article
- case report
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 45 (2), 415-421
- https://doi.org/10.1053/j.ajkd.2004.10.018
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Hemolytic Uremic SyndromePublished by Springer Nature ,2009
- Successful (?) therapy of hemolytic-uremic syndrome with factor H abnormalityPediatric Nephrology, 2003
- Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countriesJournal of Medical Genetics, 2003
- Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor HNature Genetics, 2002
- Successful treatment of factor H‐related haemolytic uraemic syndromeNephrology Dialysis Transplantation, 2002
- Hemolytic uremic syndrome: how do factor H mutants mediate endothelial damage?Trends in Immunology, 2001
- Factor H Mutations in Hemolytic Uremic Syndrome Cluster in Exons 18–20, a Domain Important for Host Cell RecognitionAmerican Journal of Human Genetics, 2001
- Clustering of Missense Mutations in the C-Terminal Region of Factor H in Atypical Hemolytic Uremic SyndromeAmerican Journal of Human Genetics, 2001
- Complement Factor H Gene Mutation Associated with Autosomal Recessive Atypical Hemolytic Uremic SyndromeAmerican Journal of Human Genetics, 1999
- The Human Factor H-related Protein 4 (FHR-4)Published by Elsevier ,1997